Evolent Health, Inc. (EVH)

NYSE • Currently up 0.04 (+0.88%) in today's trading session

1 member of Congress has disclosed 7 trades in Evolent Health, Inc. (EVH) via STOCK Act filings. The most recent disclosure was a sale by Greg Gianforte on 11 May 2020. Aggregate disclosed activity totals roughly $315K in purchases and $182.5K in sales (midpoint estimates from bracketed disclosure amounts).

Evolent Health, Inc. is currently trading at $4.58, positioned at 60% of its 52-week range ($2.10 – $6.25).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$4.58
24h Change
+0.04 (+0.88%)
52 Week Range
$2.10–$6.25
View on NASDAQ

Evolent Health, Inc. Price History and Technical Analysis

Congressional Trading Activity for EVH

Select to highlight on chart
5 transactions
Compliance: 100%
Greg Gianforte11 May 202029 May 2020SaleStock$50,001 - $100,000N/A
Greg Gianforte11 Oct 201927 Nov 2019PurchaseStock$100,001 - $250,000N/A
Greg Gianforte10 Sept 201920 Oct 2019SaleStock$50,001 - $100,000N/A
Greg Gianforte20 Dec 201823 Jan 2019PurchaseStock$15,001 - $50,000N/A
Greg Gianforte7 Jun 201815 Jun 2018PurchaseStock$50,001 - $100,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$515.16M

Volume

1.74M

Beta

0.84

P/E Ratio

35.23

Fundamentals

EPS

$0.13

Div. Yield

-

Open

$4.51

Day Range

$4.39 – $4.82

Company Information

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NYSE · USD
Country
US
CEO
Seth Barrie Blackley
IPO Date
2015-06-05

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into...

Earnings

Next Report

Q4 2026

23 Feb

EPS Est.

$0.14

Rev. Est.

$759.5M

Days Until

106

Recent Quarters

Q3 20265 Nov
EPS$0.06
Miss 1.6%
Q2 20266 Aug
EPS$0.02
Beat 292.1%
Q1 20267 May
EPS$-0.02
Beat 60.0%
Q4 202524 Feb
EPS$0.08
Beat 33.3%
Q3 20256 Nov
EPS$0.05
Miss 50.0%
Q2 20257 Aug
EPS$-0.10
Miss 211.1%
Q1 20258 May
EPS$0.06
Miss 33.3%
Q4 202420 Feb
EPS$-0.02
Miss 105.3%
Q3 20247 Nov
EPS$0.04
Miss 86.7%
Q2 20248 Aug
EPS$0.30
Beat 42.9%
Q1 20249 May
EPS$0.34
Beat 61.9%
Q4 202322 Feb
EPS$0.23
Beat 109.1%
Q3 20232 Nov
EPS$0.30
Beat 233.3%
Q2 20232 Aug
EPS$0.14
Beat 55.6%
Q1 20233 May
EPS$0.21
Beat 40.0%
Q4 202222 Feb
EPS$0.10
Beat 66.7%
Q3 20222 Nov
EPS$0.59
Beat 637.5%
Q2 20222 Aug
EPS$0.10
Beat 105.9%
Q1 20224 May
EPS$0.12
Beat 6085.6%
Q4 202123 Feb
EPS$0.08
Beat 860.4%
Q3 20213 Nov
EPS$-0.03
Miss 8.7%
Q2 20214 Aug
EPS$-0.02
Beat 66.7%
Q1 20215 May
EPS$-0.01
Beat 87.5%
Q4 202025 Feb
EPS$-0.01
Beat 80.0%
Q3 20205 Nov
EPS$-0.03
Beat 50.0%
Q2 20204 Aug
EPS$-0.03
Beat 70.0%
Q1 20207 May
EPS$-0.14
Beat 0.0%
Q4 201925 Feb
EPS$-0.07
Miss 94.4%
Q3 20195 Nov
EPS$-0.09
Beat 40.0%
Q2 20196 Aug
EPS$-0.26
Miss 13.0%
Q1 20197 May
EPS$-0.31
Beat 8.8%
Q4 201826 Feb
EPS$-0.07
Miss 72.2%
Q3 20186 Nov
EPS$-0.04
Beat 20.0%
Q2 20187 Aug
EPS$-0.03
Miss 24.1%
Q1 20189 May
EPS$0.02
Beat 152.5%
Q4 201727 Feb
EPS$-0.04
Miss 4.9%
Q3 20172 Nov
EPS$-0.04
Beat 55.6%
Q2 20177 Aug
EPS$-0.13
Beat 0.0%
Q1 20179 May
EPS$-0.14
Beat 22.2%
Q4 201628 Feb
EPS$-0.18
Beat 10.0%
Q3 20169 Nov
EPS$-0.11
Beat 15.4%
Q2 20164 Aug
EPS$-0.12
Beat 25.0%
Q1 201612 May
EPS$-0.16
Beat 15.8%
Q4 201525 Feb
EPS$-0.05
Beat 75.0%
Q3 20155 Nov
EPS$-0.16
Beat 15.8%
Q2 20157 Aug
EPS$9.80
Q2 20156 Aug
EPS$-0.45
Miss 25.0%
Q3 201431 Dec
EPS$-0.28
Q2 201430 Sept
EPS$-0.08
Q1 201430 Jun
EPS$-0.16
Q4 201331 Mar
EPS$-0.30
Q3 201331 Dec
EPS$26.25

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

FICO

Fair Isaac Corporation

42
$704.55-2.85 (-0.40%)
Technology
Held by same politician
$16M in total holdings
1 politician
View Stock

GE

GE Aerospace

25
$323.24+8.51 (+2.70%)
Industrials
Held by same politician
Significant holdings value
1 politician
View Stock

MAPTX

Matthews Pacific Tiger Investor

22
$24.09+0.42 (+1.77%)
Financial Services
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about EVH

Which members of Congress have traded EVH?
1 member of Congress has disclosed 7 trade in Evolent Health, Inc. (EVH) under the STOCK Act: Greg Gianforte.
When was EVH most recently disclosed by Congress?
The most recent EVH disclosure was a sale by Greg Gianforte on 11 May 2020.
What is the total disclosed congressional trading volume for EVH?
Members of Congress have disclosed approximately $315K in EVH purchases and $182.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in EVH?
This EVH page updates as soon as new STOCK Act disclosures are filed for Evolent Health, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.